<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d533">
    <sentence id="DDI-DrugBank.d533.s0" text="Effects of Other Drugs on Aliskiren Based on in-vitro studies, aliskiren is metabolized by CYP 3A4.">
        <entity id="DDI-DrugBank.d533.s0.e0" charOffset="26-34"
            type="drug" text="Aliskiren"/>
        <entity id="DDI-DrugBank.d533.s0.e1" charOffset="63-71"
            type="drug" text="aliskiren"/>
    </sentence>
    <sentence id="DDI-DrugBank.d533.s1" text="Co-administration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure.">
        <entity id="DDI-DrugBank.d533.s1.e0" charOffset="21-30"
            type="drug" text="lovastatin"/>
        <entity id="DDI-DrugBank.d533.s1.e1" charOffset="33-40"
            type="drug" text="atenolol"/>
        <entity id="DDI-DrugBank.d533.s1.e2" charOffset="43-50"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d533.s1.e3" charOffset="53-62"
            type="drug" text="furosemide"/>
        <entity id="DDI-DrugBank.d533.s1.e4" charOffset="65-71"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d533.s1.e5" charOffset="74-82"
            type="drug" text="celecoxib"/>
        <entity id="DDI-DrugBank.d533.s1.e6" charOffset="85-103"
            type="drug" text="hydrochlorothiazide"/>
        <entity id="DDI-DrugBank.d533.s1.e7" charOffset="106-113"
            type="drug" text="ramipril"/>
        <entity id="DDI-DrugBank.d533.s1.e8" charOffset="116-124"
            type="drug" text="valsartan"/>
        <entity id="DDI-DrugBank.d533.s1.e9" charOffset="127-135"
            type="drug" text="metformin"/>
        <entity id="DDI-DrugBank.d533.s1.e10" charOffset="141-150"
            type="drug" text="amlodipine"/>
        <entity id="DDI-DrugBank.d533.s1.e11" charOffset="206-214"
            type="drug" text="aliskiren"/>
    </sentence>
    <sentence id="DDI-DrugBank.d533.s2" text="Co-administration of irbesartan reduced aliskiren Cmax up to 50% after multiple dosing.">
        <entity id="DDI-DrugBank.d533.s2.e0" charOffset="21-30"
            type="drug" text="irbesartan"/>
        <entity id="DDI-DrugBank.d533.s2.e1" charOffset="40-48"
            type="drug" text="aliskiren"/>
        <ddi id="DDI-DrugBank.d533.s2.d0" e1="DDI-DrugBank.d533.s2.e0"
            e2="DDI-DrugBank.d533.s2.e1" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d533.s3" text="Co-administration of atorvastatin resulted in about a 50% increase in aliskiren Cmax and AUC after multiple dosing.">
        <entity id="DDI-DrugBank.d533.s3.e0" charOffset="21-32"
            type="drug" text="atorvastatin"/>
        <entity id="DDI-DrugBank.d533.s3.e1" charOffset="70-78"
            type="drug" text="aliskiren"/>
        <ddi id="DDI-DrugBank.d533.s3.d0" e1="DDI-DrugBank.d533.s3.e0"
            e2="DDI-DrugBank.d533.s3.e1" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d533.s4" text="Ketoconazole: Co-administration of 200 mg twice-daily ketoconazole with aliskiren resulted in an approximate 80% increase in plasma levels of aliskiren.">
        <entity id="DDI-DrugBank.d533.s4.e0" charOffset="0-11"
            type="drug" text="Ketoconazole"/>
        <entity id="DDI-DrugBank.d533.s4.e1" charOffset="54-65"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d533.s4.e2" charOffset="72-80"
            type="drug" text="aliskiren"/>
        <entity id="DDI-DrugBank.d533.s4.e3" charOffset="142-150"
            type="drug" text="aliskiren"/>
        <ddi id="DDI-DrugBank.d533.s4.d0" e1="DDI-DrugBank.d533.s4.e1"
            e2="DDI-DrugBank.d533.s4.e2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d533.s5" text="A 400 mg once-daily dose was not studied but would be expected to increase aliskiren blood levels further.">
        <entity id="DDI-DrugBank.d533.s5.e0" charOffset="75-83"
            type="drug" text="aliskiren"/>
    </sentence>
    <sentence id="DDI-DrugBank.d533.s6" text="Effects of Aliskiren on Other Drugs Aliskiren does not inhibit the CYP450 isoenzymes (CYP1A2, 2C8, 2C9, 2C19, 2D6, 2E1, and CYP 3A) or induce CYP 3A4.">
        <entity id="DDI-DrugBank.d533.s6.e0" charOffset="11-19"
            type="drug" text="Aliskiren"/>
        <entity id="DDI-DrugBank.d533.s6.e1" charOffset="36-44"
            type="drug" text="Aliskiren"/>
    </sentence>
    <sentence id="DDI-DrugBank.d533.s7" text="Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.">
        <entity id="DDI-DrugBank.d533.s7.e0" charOffset="21-29"
            type="drug" text="aliskiren"/>
        <entity id="DDI-DrugBank.d533.s7.e1" charOffset="84-93"
            type="drug" text="lovastatin"/>
        <entity id="DDI-DrugBank.d533.s7.e2" charOffset="96-102"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d533.s7.e3" charOffset="105-113"
            type="drug" text="valsartan"/>
        <entity id="DDI-DrugBank.d533.s7.e4" charOffset="116-125"
            type="drug" text="amlodipine"/>
        <entity id="DDI-DrugBank.d533.s7.e5" charOffset="128-136"
            type="drug" text="metformin"/>
        <entity id="DDI-DrugBank.d533.s7.e6" charOffset="139-147"
            type="drug" text="celecoxib"/>
        <entity id="DDI-DrugBank.d533.s7.e7" charOffset="150-157"
            type="drug" text="atenolol"/>
        <entity id="DDI-DrugBank.d533.s7.e8" charOffset="160-171"
            type="drug" text="atorvastatin"/>
        <entity id="DDI-DrugBank.d533.s7.e9" charOffset="174-181"
            type="drug" text="ramipril"/>
        <entity id="DDI-DrugBank.d533.s7.e10" charOffset="186-204"
            type="drug" text="hydrochlorothiazide"/>
    </sentence>
    <sentence id="DDI-DrugBank.d533.s8" text="Warfarin: The effects of aliskiren on warfarin pharmacokinetics have not been evaluated in a well-controlled clinical trial.">
        <entity id="DDI-DrugBank.d533.s8.e0" charOffset="0-7"
            type="drug" text="Warfarin"/>
        <entity id="DDI-DrugBank.d533.s8.e1" charOffset="25-33"
            type="drug" text="aliskiren"/>
        <entity id="DDI-DrugBank.d533.s8.e2" charOffset="38-45"
            type="drug" text="warfarin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d533.s9" text="Furosemide: When aliskiren was co-administered with furosemide, the AUC and Cmax of furosemide were reduced by about 30% and 50%, respectively.">
        <entity id="DDI-DrugBank.d533.s9.e0" charOffset="0-9"
            type="drug" text="Furosemide"/>
        <entity id="DDI-DrugBank.d533.s9.e1" charOffset="17-25"
            type="drug" text="aliskiren"/>
        <entity id="DDI-DrugBank.d533.s9.e2" charOffset="52-61"
            type="drug" text="furosemide"/>
        <entity id="DDI-DrugBank.d533.s9.e3" charOffset="84-93"
            type="drug" text="furosemide"/>
        <ddi id="DDI-DrugBank.d533.s9.d0" e1="DDI-DrugBank.d533.s9.e1"
            e2="DDI-DrugBank.d533.s9.e2" type="mechanism"/>
    </sentence>
</document>
